What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$3.6M open-market purchase by David Efraim Rosen, 10% Owner at Heron Therapeutics,inc. /DE/, filed August 12, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Insider purchase
David Efraim Rosen, a 10% beneficial owner, reported a $3.6M open-market purchase equal to 1.5% of HRTX's market cap.
David Efraim Rosen (10% Owner) bought 2,387,225 shares of HRTX, Heron Therapeutics,inc. /DE/, Healthcare ($232.0M market cap), at $1.50 per share on August 8, 2025 for a total of $3.6M (1.5% of the market cap).
Permalink https://bluecollarpicks.com/insider-trading/HRTX/buy/40780
Market context
Last enriched May 6, 2026 at 8:00 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning.
| Ticker | Type & Role | Value | Filed |
|---|---|---|---|
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Exercise and Hold CEO | Not reported | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Officer | $0 | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Grant Officer | $0 | ||
Grant Director | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Director | $0 | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Cluster Buy Director | $2.6M | ||
Cluster Buy 10% Owner | $3.6M | ||
| This filing | Cluster Buy 10% Owner | $3.6M | |
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method
Ready-made views give you a clear starting point before you touch filters.
Cluster buys mean multiple insiders buying the same ticker inside a short window.
Rows preserve filing date, trade date, role, value, and source links where available.
Filtered rows are not hidden. Grants, exercises, tax withholding, gifts, and conversions stay available in All Form 4 Filings, ticker history, and specialized views.
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.